Indeed, one recently published paper demonstrated that only a combined treatment with pan class I/II HDACIs (e.g., LBH‐589) and PI3Ki (BKM‐120) can effectively inhibit the growth of aggressive MYC‐driven medulloblastoma in mice (Tzivion et al, 2011). Here, MYC is linked to medulloblastoma.